MedTrace Logo

Fecal Transplant for MDR Pathogen Decolonization

NCT02906774 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2019-12-02

No results posted yet for this study

Summary

This is a proof-of-principle research study designed to determine whether fecal microbiota transplantation (FMT) can eliminate highly drug-resistant bacteria from the intestinal tract of renal transplant patients. The primary goal of this study is to test whether oral gut decontamination followed by FMT by enema delivery will result in decolonization of the intestinal tract of renal transplant patients shortly after solid organ transplantation, thereby preventing difficult to treat post-transplant infections.

Conditions

  • Multi-antibiotic Resistance

Interventions

BIOLOGICAL

Fecal microbiota transplantation (FMT)

Fecal microbiota transplantation after antibiotic pretreatment

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Amee Manges, MPH, PhD · University of British Columbia

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02906774 on ClinicalTrials.gov